• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
CHEN Shixian,LIANG Xiaoxiao,SHI Haiyan,ZHANG Pei,LIN Xiaoqing,HUANG Xin.Determination of Pamiparib in plasma of cancer patients by LC-MS / MS method[J].Journal Of Pharmaceutical Research,2024,43(5):439-443[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3041times   Download 2922次 QR Code for this article
Scan with your phone!
LC-MS/MS法测定肿瘤患者血浆中帕米帕利浓度
陈世贤1,梁笑笑1,时海燕2,张霈3,林晓晴2,黄欣1,2,3
Font:Larger+|Default|Smaller-
(1.山东中医药大学药学院,山东 济南 250355;2.山东第一医科大学第一附属医院<山东省千佛山医院>药学部,山东 济南 250014;3.山东第一医科大学药学院,山东 济南 250117)
摘要:
目的 建立液相色谱-质谱联用 (LC-MS/MS) 法测定肿瘤患者血浆中帕米帕利浓度的方法。方法 使用乙腈沉淀血浆蛋白,以呋塞米为内标,采用LC-MS/MS测定帕米帕利的血药浓度。采用GL Sciences ODS-4色谱柱,以含0.1%甲酸水溶液为流动相A,甲醇为流动相B,进行梯度洗脱,流速为0.25 mL•min-1,柱温35 ℃,进样量为2 μL;采用电喷雾离子源,负离子扫描,多反应监测模式,用于定量分析的帕米帕利离子对为m/z 297.3→m/z 253.1。结果 帕米帕利检测质量浓度的线性范围为100~10 000 ng•mL-1(r=0.995 4),定量下限为100 ng•mL-1;批内和批间准确度在92.0%~106.5%之间,批内和批间精密度均小于8.3%,基质效应、稳定性、选择性、残留均符合指导原则要求。临床患者帕米帕利体内随机血药浓度在330~1 693 ng•mL-1之间。结论 所建方法操作简便、快速,可用于帕米帕利的血药浓度测定。
关键词:  帕米帕利  液相色谱-质谱联用  血药浓度测定
DOI:10.13506/j.cnki.jpr.2024.05.005
基金项目:2022白求恩·求索-药学科研能力建设项目
Publication Date:May 25, 2024
Determination of Pamiparib in plasma of cancer patients by LC-MS / MS method
CHEN Shixian1,LIANG Xiaoxiao1,SHI Haiyan2,ZHANG Pei3,LIN Xiaoqing2,HUANG Xin1,2,3
(1.School of Pharmacy ,Shandong University of Traditional Chinese Medicine ,Jinan 250355 ,China;2. Department of Pharmacy, the First Affiliated Hospital of Shandong First Medical University(Shandong Provincial Qianfoshan Hospital),Jinan 250014,China; 3.School of Pharmacy ,Shandong First Medical University ,Jinan 250000,China)
Abstract:
Objective To establish a liquid chromatography-mass spectrometry (LC-MS/MS) method for the determination of Pamidronate concentration in plasma of cancer patients.Methods Acetonitrile was used to precipitate plasma protein, and furosemide was used as the internal standard. The plasma concentration of Pamiparib was determined by LC-MS/MS. GL Sciences ODS-4 chromatographic column was used for gradient elution. The mobile phase A was 0.1% formic acid aqueous solution, and the mobile phase B was methanol. The flow rate was 0.25 mL•min-1, the column temperature was 35 ℃,and the injection volume was 2 μL. Negative ion scanning was performed using an electrospray ion source in a multi-reaction monitoring mode. The Pamiparib ion pair used for quantitative analysis was m/z 297.3→m/z 253.1. Results The linear range of Pamiparib was 100~10 000 ng•mL-1(r=0.995 4), and the lower limit of quantification was 100 ng•mL-1. The intra-batch and inter-batch accuracies were between 92.0% and 106.5%, and the intra-batch and inter-batch precisions were less than 8.3%. The matrix effect, stability, selectivity and residue all meet the requirements of the guiding principles. The random plasma concentration of Pamiparib in clinical patients was between 330-1 693 ng•mL-1. Conclusion The established method is simple and rapid, and can be used for the determination of plasma concentration of Pamiparib
Key words:  Pamiparib  LC-MS/MS  Determination of blood concentration
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.